Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis - Test2 - elhamkhani - TriplyDB

Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis

Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis

http://www.wikidata.org/entity/Q28291143

about

Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy Recent advances in understanding idiopathic pulmonary fibrosis Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib Idiopathic pulmonary fibrosis: Diagnosis, epidemiology and natural history Understanding Idiopathic Interstitial Pneumonia: A Gene-Based Review of Stressed Lungs Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis Molecular classification of idiopathic pulmonary fibrosis: personalized medicine, genetics and biomarkers Is there still hope for single therapies: how do we set up experimental systems to efficiently test combination therapies?Cellular mechanisms of tissue fibrosis. 7. New insights into the cellular mechanisms of pulmonary fibrosis A roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung disease Molecular biomarkers in idiopathic pulmonary fibrosis Genetic susceptibility and pulmonary fibrosis Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis YKL-40 in pediatric asthma, MUC5B promoter polymorphism in idiopathic pulmonary fibrosis, and esmolol in septic shock.Pathogenesis of idiopathic pulmonary fibrosis Pathogenesis of idiopathic pulmonary fibrosis: review of recent findings.Genetics and early detection in idiopathic pulmonary fibrosis Familial Interstitial Pneumonia (FIP).Sequencing of idiopathic pulmonary fibrosis-related genes reveals independent single gene associations The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis CT scan findings of probable usual interstitial pneumonitis have a high predictive value for histologic usual interstitial pneumonitis The MUC5B promoter polymorphism is associated with idiopathic pulmonary fibrosis in a Mexican cohort but is rare among Asian ancestries.Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct?Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension.Update in diffuse parenchymal lung disease, 2013 Genome sequencing of idiopathic pulmonary fibrosis in conjunction with a medical school human anatomy course.Genetics of Interstitial Lung Disease: Vol de Nuit (Night Flight).Models of disease behavior in idiopathic pulmonary fibrosis.Incorporating genetics into the identification and treatment of Idiopathic Pulmonary Fibrosis The Microbiome and the Respiratory Tract Lost after translation: insights from pulmonary surfactant for understanding the role of alveolar epithelial dysfunction and cellular quality control in fibrotic lung disease.MUC5B expression and location in surfactant protein C mutations in children.A protective role for IL-13 receptor α 1 in bleomycin-induced pulmonary injury and repair Association between MUC5B polymorphism and susceptibility and severity of idiopathic pulmonary fibrosis.Rationale for and design of the Idiopathic Pulmonary Fibrosis-PRospective Outcomes (IPF-PRO) registry.

P2860

Q26738458-2B940221-41BA-4BFD-A470-B5254410832C Q26745905-A089C399-C762-4217-AF58-C48D7CB1465E Q26771647-D6236C7C-34E7-4C42-B6FA-371735FB8FB0 Q26776473-CB8781FE-3707-45EF-9329-43DF5001B9D3 Q26779192-1B55F607-101E-40AE-B931-E338EAE4865E Q26849378-7B88F54D-3031-46C6-ADB6-3192560D1213 Q26864836-37DA7A7E-0797-4FE1-ABEB-2742D9FA631A Q26998459-DC68705E-8F94-4C69-8EC9-A014B18DE8A2 Q27003892-7FE32FDD-0E48-4705-9C3A-D64D1B52C324 Q27014138-20F05703-0AC3-4CE0-98A2-D42FBF05894C Q27025340-94035F07-F8AA-4BDF-AAA5-1AC1AD97F9C9 Q28243802-19336708-070B-4F79-832B-C4898D1D6A56 Q29248145-DD20A95B-CD0A-49FF-B6A1-44385EB3E281 Q30384494-E79B6ADA-FC09-4208-8125-CBEB9B2988DE Q33574837-82DC6BDD-7B45-4BF8-A988-3A584BB21A5C Q33601748-40F0F41D-5A82-4B4E-8383-31D1AC0177C5 Q33714064-612D57EC-898E-4A52-98CA-2573EE9F5736 Q33732174-0240C38B-1E34-43CD-82EE-13D5E726B9A4 Q33976506-4E1B81DB-CA5E-496B-97D0-FF540CC62145 Q34019921-FEFCC3A2-A69B-4E2C-BCAB-1B19769DAA44 Q34479395-46D78967-D186-4A4E-B752-8F621D22FD17 Q34678023-4C4765BD-B0CA-481A-9A13-0FAD6456B043 Q34692137-A45FCBFF-4353-454A-ADF8-3A5F3BEBCDD4 Q34935466-B578F98B-0972-487E-BE59-92341667AA83 Q34986902-8F7EA3D0-61F9-408B-88AB-79AA27F615B8 Q35041517-21347303-A4EB-4018-AE3C-F22C33827C0E Q35041524-D2A1E449-3CC6-44AB-B83E-83D51EC02BF7 Q35121494-E69AF451-7356-4EB8-9B98-20FF000F0CA0 Q35140747-0D9DDF6D-E4C4-4D18-975A-E020809FE3F6 Q35153423-6EF7C22B-A7F9-48DD-A568-C366B1B0999B Q35239965-D0D11551-0F0B-4933-9C78-1E837E4FF446 Q35649228-F21A40F1-C626-424F-AF4E-8229E5525463 Q35786052-1E64BEDD-66C6-4E3A-ACE3-8214133D7C95 Q35786160-7DD5424E-DAF9-4C25-AF90-BC014A439502 Q35829947-7377C008-87B2-4A5B-8310-C970877FDBCC Q36066466-B5F3164B-703A-4AD2-B7FD-C966DE5C6870 Q36132579-3F44EE21-A0C0-40DB-9C43-33DB4AB07A7C Q36438280-8A1B8C94-8F6A-40C9-AA73-E4618A757EA0 Q36464726-E778FE2C-4430-4CAA-B70B-4FF9EC51F0B0 Q36472166-559EED6B-FC1D-4C3C-A309-BC9C9868FEA4

P2860

Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis

http://www.wikidata.org/entity/Q28291143

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Association between the MUC5B ...... idiopathic pulmonary fibrosis

@ast

Association between the MUC5B ...... idiopathic pulmonary fibrosis

@en

Association between the MUC5B ...... idiopathic pulmonary fibrosis

@nl

type

label

Association between the MUC5B ...... idiopathic pulmonary fibrosis

@ast

Association between the MUC5B ...... idiopathic pulmonary fibrosis

@en

Association between the MUC5B ...... idiopathic pulmonary fibrosis

@nl

prefLabel

Association between the MUC5B ...... idiopathic pulmonary fibrosis

@ast

Association between the MUC5B ...... idiopathic pulmonary fibrosis

@en

Association between the MUC5B ...... idiopathic pulmonary fibrosis

@nl

P1433

Q28291143-49DDDC90-13BB-47ED-8C59-EC4C7706195F

P1476

Q28291143-8299C6AA-EF3F-4A3C-942A-6B082A223E90

P2093

Q28291143-0221E2EF-69E9-4FCE-821C-28278A566F80

Q28291143-1288A317-7984-4F04-ACAC-8104E1C580F0

Q28291143-3CEEB220-FE39-4173-A004-7BCFA0B3C23A

Q28291143-400DE90E-E811-484B-B6D3-02F6B105C92C

Q28291143-528FEF57-BF76-4A9C-85C9-DE08A2CD8874

Q28291143-59673A4A-4732-45D4-BFA7-6A2529791E65

Q28291143-6439739C-613C-4C47-88B9-E5FBA6995037

Q28291143-6A294470-E28E-4CB9-AE4B-D41B54E5A586

Q28291143-82CC4371-4FB5-4030-A8EB-23E60136B9C9

Q28291143-92629E57-29FC-4877-B457-2DA4E229EDC1

P2860

Q28291143-03412983-6FFC-4CC7-B2FF-A7C5A9FFB1D5

Q28291143-08B4A017-F34E-4B3C-B714-D90222F6CEF6

Q28291143-1116B8B7-160F-48B9-9AF5-EC3C4635B61C

Q28291143-1E61B061-17E5-4AE0-BC96-D8BA9C249CEE

Q28291143-1EC6BFB5-E178-4013-9196-4DC1BD57F22B

Q28291143-2C9E41BD-0884-4DDC-83E6-C07466473D9A

Q28291143-2D364211-8827-4FC3-8BAB-E519DCBD807C

Q28291143-443169BB-B72D-43C1-AC9C-6CF6A2030F1A

Q28291143-51880536-0465-4693-B7F0-E69DE3A5D7F2

Q28291143-63994280-00C4-4A4C-9758-BFAC6F5FECF4

P304

Q28291143-5F801594-2161-4E7B-8161-3D11FE39229E

P31

Q28291143-AC063A5B-B019-4E58-85B8-E7EA574C168E

P3181

Q28291143-D08B5861-C1B4-47D1-81C4-E3575EF8FD2D

P356

Q28291143-A3AD3407-0AC9-4CAF-A6D1-10628FC96B55

P407

Q28291143-2C2EAAA9-3566-4337-99D9-39CF51DFE950

P433

Q28291143-569DD7BC-CFFF-4DCC-8F03-E431CBEFA9CC

P478

Q28291143-28234991-CEB6-46DC-97F6-AB64C2BB82F9

P50

Q28291143-A4CEC6D1-5C95-4939-8E3C-B4D7C05BF69E

P577

Q28291143-5E80FC1A-A7F8-4859-8C45-144F842FCBA5

P5875

Q28291143-F45796DC-92FD-4C4B-8F9C-F0478109B190

P698

Q28291143-DFC7B2DD-BC16-4894-A09E-314AC77F1FE3

P921

Q28291143-6E980D0B-9941-44C6-9419-CF9D0B0D8D3D

Q28291143-8C8D4719-FB9A-41A4-8993-3777B4C6D386

Q28291143-8ECB71E9-6300-4BFF-B842-020DE9A53A7E

P932

Q28291143-A5EE2C2A-0698-40EC-A62E-9FE119A27A43

P3181

P356

P1433

Journal of the American Medical Association

P1476

Association between the MUC5B ...... idiopathic pulmonary fibrosis

@en

P2093

Anna L Peljto

http://www.w3.org/2001/XMLSchema#string

Cheryl Markin

http://www.w3.org/2001/XMLSchema#string

David A Schwartz

http://www.w3.org/2001/XMLSchema#string

Elissa Murphy

http://www.w3.org/2001/XMLSchema#string

Imre Noth

http://www.w3.org/2001/XMLSchema#string

James E Loyd

http://www.w3.org/2001/XMLSchema#string

Janet L Talbert

http://www.w3.org/2001/XMLSchema#string

Joe G N Garcia

http://www.w3.org/2001/XMLSchema#string

Karl Kossen

http://www.w3.org/2001/XMLSchema#string

Kathleen O Lindell

http://www.w3.org/2001/XMLSchema#string

P2860

A mutation in the surfactant protein C gene associated with familial interstitial lung disease

Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis

MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis

Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis

Telomerase mutations in families with idiopathic pulmonary fibrosis

Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer.

Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis (IPF).

Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model.

P304

2232-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

332857

http://www.w3.org/2001/XMLSchema#string

P356

10.1001/JAMA.2013.5827

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

309

http://www.w3.org/2001/XMLSchema#string

P50

Naftali Kaminski

P577

2013-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236929393

http://www.w3.org/2001/XMLSchema#string

P698

23695349

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

4545271

http://www.w3.org/2001/XMLSchema#string